Latest / AVBCC Value-Based Voices

Can the U.S. Keep Its Edge? FDA Policy, China’s Momentum, and the Future of Innovation
In this follow up conversation, Jayson Slotnik, JD, MPH, Partner at Health Policy Strategies and AVBCC Board Members, and Steve Usdin, Senior Editor, Washington, BioCentury Publications, take a clear eyed look at the future of the FDA and the forces shaping biopharmaceutical innovation. Building on their earlier discussion of FDA history and political dynamics, Steve offers candid insights into how U.S. policy, global competition - particularly with China - and shifting regulatory priorities are influencing the life sciences ecosystem.
He explores:
- the implications of NIH funding erosion
-…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.